Cargando…

The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma

We examined a set of 805 cases that underwent DNA sequencing using the FoundationOne Heme (F1H) targeted sequencing panel and gene expression profiling. Known and likely variant calls from the mutational data were analyzed for significant associations with gene expression defined translocation cycli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stein, Caleb K., Pawlyn, Charlotte, Chavan, Shweta, Rasche, Leo, Weinhold, Niels, Corken, Adam, Buros, Amy, Sonneveld, Pieter, Jackson, Graham H., Landgren, Ola, Mughal, Tariq, He, Jie, Barlogie, Bart, Bergsagel, P. Leif, Davies, Faith E., Walker, Brian A., Morgan, Gareth J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438613/ https://www.ncbi.nlm.nih.gov/pubmed/28427158 http://dx.doi.org/10.18632/oncotarget.15718

Ejemplares similares

The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
por: Rasche, Leo, et al.
Publicado: (2022)

Decoding RAS isoform and codon-specific signalling
por: Newlaczyl, Anna U., et al.
Publicado: (2014)

Removing batch effects from purified plasma cell gene expression microarrays with modified ComBat
por: Stein, Caleb K, et al.
Publicado: (2015)

K-ras oncogene codon 12 point mutations in testicular cancer.
por: Ridanpää, M, et al.
Publicado: (1993)

Activation of K-RAS by co-mutation of codons 19 and 20 is transforming
por: Naguib, Adam, et al.
Publicado: (2011)

Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma.
por: Czerniak, B., et al.
Publicado: (1990)

Point mutation at codon 12 of the c-Ha-ras gene in human gastric cancers.
por: Koh, E. H., et al.
Publicado: (1992)

Exploiting codon usage identifies intensity-specific modifiers of Ras/MAPK signaling in vivo
por: Sawyer, Jessica K., et al.
Publicado: (2020)

Molecular profiling in myeloma
por: Pawlyn, Charlotte, et al.
Publicado: (2018)

Walter Michael Kuehl, MD - October 25, 1939 - April 30, 2023
por: Bergsagel, Leif
Publicado: (2023)

Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors.
por: Capella, G, et al.
Publicado: (1991)

Lower Incidence of K‐ras Codon 12 Mutation in Flat Colorectal Adenomas than in Polypoid Adenomas
por: Yamagata, Seiichi, et al.
Publicado: (1994)

Ancestral Inference and the Study of Codon Bias Evolution: Implications for Molecular Evolutionary Analyses of the Drosophila melanogaster Subgroup
por: Akashi, Hiroshi, et al.
Publicado: (2007)

Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia
por: Atrash, Shebli, et al.
Publicado: (2017)

Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine
por: Smith, G, et al.
Publicado: (2010)

Transforming Activity of a Synthetic c‐Ha‐ras Gene Containing O(6)‐Methylguanine in Codon 12
por: Kamiya, Hiroyuki, et al.
Publicado: (1991)

Variation in K‐ras Codon 12 Point Mutation Rate with Histological Atypia within Individual Colorectal Tumors
por: Sob, Kontae, et al.
Publicado: (1993)

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
por: Landgren, Ola, et al.
Publicado: (2019)

Maternal Obesity Programming of Perivascular Adipose Tissue and Associated Immune Cells: An Understudied Area With Few Answers and Many Questions
por: Corken, Adam, et al.
Publicado: (2022)

Detection of codon 12 K- ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung adenocarcinomas
por: Urban, T, et al.
Publicado: (2000)

Frequent Glycine‐to‐Aspartic Acid Mutations at Codon 12 of c‐Ki‐ras Gene in Human Pancreatic Cancer in Japanese
por: Nagata, Yasuhiko, et al.
Publicado: (1990)

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2019)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
por: Davies, Faith E., et al.
Publicado: (2022)

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
por: Chavan, S S, et al.
Publicado: (2017)

High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site
por: Chavan, Tanmay S., et al.
Publicado: (2015)

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control
por: Pawlyn, C, et al.
Publicado: (2017)

High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India.
por: Saranath, D., et al.
Publicado: (1991)

Codon 12 Ki-ras mutation in non-small-cell lung cancer: comparative evaluation in tumoural and non-tumoural lung.
por: Urban, T., et al.
Publicado: (1996)

Revisiting checkpoint inhibitors for myeloma: maintenance after stem cell transplant
por: Meermeier, Erin W., et al.
Publicado: (2023)

Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia
por: Isobe, Tomoya, et al.
Publicado: (2022)

Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?
por: Pawlyn, Charlotte, et al.
Publicado: (2018)

Prevalence of K-RAS Codons 12 and 13 Mutations in Locally Advanced Head and Neck Squamous Cell Carcinoma and Impact on Clinical Outcomes
por: Bissada, Eric, et al.
Publicado: (2013)

Frequency and Types of Point Mutation at the 12th Codon of the c‐Ki‐ras Gene Found in Pancreatic Cancers from Japanese Patients
por: Mariyama, Mariko, et al.
Publicado: (1989)

Review of Multiple Myeloma Genetics including Effects on Prognosis, Response to Treatment, and Diagnostic Workup
por: Wiedmeier-Nutor, Julia Erin, et al.
Publicado: (2022)

Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
por: Landgren, Ola, et al.
Publicado: (2023)

Codon usage and codon context bias in Xanthophyllomyces dendrorhous
por: Baeza, Marcelo, et al.
Publicado: (2015)

The LIM-Only Protein FHL2 Mediates Ras-Induced Transformation through Cyclin D1 and p53 Pathways
por: Labalette, Charlotte, et al.
Publicado: (2008)

Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS
por: Taylor-Harding, Barbie, et al.
Publicado: (2014)

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
por: Rasche, L., et al.
Publicado: (2017)

Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma
por: Davies, Faith E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vrf5mgm8un9hd5mrgsj2v7lkar